tetradecanoylphorbol acetate has been researched along with tirofiban in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelmeijer, J; De Groot, PG; Lisman, T; Moschatsis, S; Nieuwenhuis, HK | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and tirofiban
| Article | Year |
|---|---|
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Blood Platelets; Cells, Cultured; Collagen; Drug Evaluation, Preclinical; Endothelium, Vascular; Eptifibatide; Extracellular Matrix; Factor VIIa; Factor X; Hemorheology; Humans; Immunoglobulin Fab Fragments; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thrombasthenia; Thrombin; Thromboplastin; Tirofiban; Tyrosine | 2003 |